| Financial Year |
March 31 2023 |
| Monetary Funds |
449,873,495.23 |
| Held-for-trading Financial Assets |
20,772.20 |
| Notes Receivable |
8,245,960.50 |
| Accounts Receivable |
61,097,904.33 |
| Advances to Suppliers |
942,161.78 |
| Other Receivables |
5,151,723.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,834,277.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,164,710.67 |
| Total Current Assets |
592,021,500.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
498,029,233.82 |
| Investment Properties |
222,966,427.09 |
| Fixed Assetes |
463,279,509.56 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
156,106,379.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
909,669.95 |
| Deferred Income Tax Assets |
811,254.06 |
| Other Non-Current Assets |
276,335.00 |
| Sub-Total of Non-Current Assets |
1,890,680,094.82 |
| Total Assets |
2,482,701,595.24 |
| Short-Term Loans |
435,948,502.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,604,425.38 |
| Accounts Payable |
132,869,329.76 |
| Accounts Received In Advance |
340,667.26 |
| Employee Compensation Payable |
79,222,967.69 |
| Taxes Payable |
12,367,995.42 |
| Interest Payable |
-- |
| Dividend Payable |
2,857,265.76 |
| Other payables |
11,433,464.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,672,816.80 |
| Other Current Liabilities |
6,538,979.94 |
| Sub-Total of Current Liabilities |
788,117,110.42 |
| Long-term Loans |
285,105,528.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
296,601,896.68 |
| Total Liabilities |
1,084,719,007.10 |
| Paid-In Capital(Or Share Stock) |
344,708,340.00 |
| Capital Surplus |
25,564,872.42 |
| Surplus Reserve |
97,819,200.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
830,230,330.09 |
| Minority Stockholder's Interest |
86,295,213.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,311,687,374.66 |
| Owner's Equity（Stockholder's Equity） |
1,397,982,588.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,482,701,595.24 |
